SR 57746A: An Orally Active Non‐Peptide Compound with Neurotrophic and Neuroprotective Effects
Open Access
- 1 June 1997
- journal article
- Published by Wiley in CNS Drug Reviews
- Vol. 3 (2) , 148-167
- https://doi.org/10.1111/j.1527-3458.1997.tb00321.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- SR 57746A attenuates cytostatic drug-induced reduction of neurite outgrowth in co-cultures of rat dorsal root ganglia and Schwann cellsNeuroscience Letters, 1996
- Facilitating effects of SR 57746A on short-term memory in an operant delayed alternation task in aged ratsDrug Development Research, 1995
- Neurotrophic factor therapy for nervous system degenerative diseasesJournal of Neurobiology, 1994
- Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivoNature, 1994
- Biochemical and electrophysiological properties of SR 57746A, a new, potent 5‐HT1A receptor agonistFundamental & Clinical Pharmacology, 1993
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- The small GTP-binding protein rac regulates growth factor-induced membrane rufflingCell, 1992
- The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factorsCell, 1992
- Growth factor signaling: Where is the specificity?Cell, 1992
- 6‐Methylmercaptopurine Riboside Is a Potent and Selective Inhibitor of Nerve Growth Factor‐Activated Protein Kinase NJournal of Neurochemistry, 1992